Brighten breaks down how perimenopause and menopause shift insulin sensitivity, fat distribution, appetite, and recovery and where glucagon-like peptide-1 (GLP-1) receptor agonists (think semaglutide/Ozempic, Wegovy, liraglutide, tirzepatide as a related incretin therapy) can fit safely alongside hormone therapy, lifting, protein, and smart lab work
On the other hand, IGF-1 LR3 shows a role in biological ageing and helps us in understanding of IGF1 system []]
Protecting Liver Cells (Hepatocytes) As the liver filters out alcohol, environmental pollutants, and processed food byproducts, it generates a lot of "exhaust" in the form of free radicals
Alleviation of Depression by glucagon-like peptide 1 Through the regulation of neuroinflammation, neurotransmitters, neurogenesis, and synaptic function